Granza Bio Analysis: $7M Raised
What is Granza Bio?
Granza Bio develops precision shell technology to deliver immune-inspired therapeutic agents, targeting diseases such as cancer and infections.
Founded
2024
Revenue
$5M
Company Stage
Seed
Investors
- Felicis Ventures
- Y Combinator
- Refactor Capital
YC Batch
W24
Product Features & Capabilities
- Precision shell technology, targeted therapeutic delivery, cancer treatment, autoimmune disease treatment, delivery of genetic modifiers, packaging of attack particles, RNAs, and proteins, overcoming immunological activation, targeting hard-to-reach organs.
How much Granza Bio raised
Seed - $7M
July 3, 2024Lead Investor: Felicis and Y Combinator
Who are the founders of Granza Bio
AN
Ashwin Nandakumar
Founder
AJ
Ashwin Jainarayanan
Founder
Find more companies like Granza Bio
See something that needs updating? Suggest edits to this profile.
